
Abstract
Objectives The cluster randomised trial of the Data driven Quality Improvement in Primary Care (DQIP) intervention showed that education, informatics and financial incentives for general medical practices to review patients with ongoing high-risk prescribing of non-steroidal anti-inflammatory drugs and antiplatelets reduced the primary end point of high-risk prescribing by 37%, where both ongoing and new high-risk prescribing were significantly reduced. This quantitative process evaluation examined practice factors associated with (1) participation in the DQIP trial, (2) review activity (extent and nature of documented reviews) and (3) practice level effectiveness (relative reductions in the primary end point).
Item Type: | Journal article |
---|---|
Faculties: | Medicine > Institute for General Medicine |
Subjects: | 600 Technology > 610 Medicine and health |
URN: | urn:nbn:de:bvb:19-epub-68597-1 |
ISSN: | 2044-6055 |
Language: | English |
Item ID: | 68597 |
Date Deposited: | 29. Aug 2019, 07:11 |
Last Modified: | 04. Nov 2020, 13:51 |